-
In this prospective, longitudinal study of 195 patients, it was found that patients who survived acute respiratory distress syndrome (ARDS) have persistent functional limitation 1 year post-ICU discharge secondary to extrapulmonary limitation.
-
-
The FDA has recently approved a vaginal estrogen ring for the treatment of symptoms associated with menopause. The self-inserted ring releases 50 mg or 100 mg of estradiol daily for 3 months.
-
The use of oral contraceptives in women with hypertension produced higher blood pressures and poor control of blood pressure.
-
Adefovir dipivoxil, 10 mg p.o. daily, is safe and effective in the treatment of chronic hepatitis due to HBV, regardless of the presence or absence of HBeAg, and it did not select resistant mutants after 48 weeks of administration.
-
When it comes to emergency contraception (EC), does its availability and use impact ongoing contraceptive methods? Initial research from one study indicates that adolescent mothers who are given a supply of EC are no less likely to use condoms and other forms of birth control than teen mothers who are not given EC.
-
Your next patient is a young married woman who is unable to use hormonal birth control and is not interested in using an intrauterine device. Because she wants to have more children, sterilization is not an option at the present time. What contraceptive methods are available to her?
-
It is estimated some 50 million women in the United States are screened on an annual basis with Pap tests. Clinicians now have another tool in their arsenal that will help distinguish women at increased risk of developing cervical cancer from those at very low risk.
-
-
Since the NuvaRing contraceptive vaginal ring (Organon, West Orange, NJ) entered the U.S. market in mid-2002, new research has been published that underscores its efficacy and acceptability.